Zobrazeno 1 - 10
of 21
pro vyhledávání: '"I. Alsharoqi"'
Autor:
Murat Kürtüncü, Mohammed Aljumah, Abdulkader Daif, Slassi I, El-Koussa S, Jihad Inshasi, Mohammed A. Sahraian, Saeed Bohlega, Karim Taha, I. Alsharoqi, Cavit Boz, Retief C, Shaygannejad, Thomas Müller, Sørensen Ps, Magd Zakaria
Publikováno v:
Neurology and Therapy
Neurology and Therapy, Vol 9, Iss 1, Pp 55-66 (2020)
Neurology and Therapy, Vol 9, Iss 1, Pp 55-66 (2020)
The majority of disease-modifying drugs (DMDs) available for the management of active relapsing–remitting multiple sclerosis (RMS) depend on continuous drug intake for maintained efficacy, with escalation to a more active drug when an unacceptable
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c41be2cf927bf723494ec93f937d199d
https://doi.org/10.1007/s40120-020-00187-3
https://doi.org/10.1007/s40120-020-00187-3
Autor:
Mohammed Aljumah, Raed Alroughani, I. Alsharoqi, Saeed A. Bohlega, Maurice Dahdaleh, Dirk Deleu, Khaled Esmat, Ahmad Khalifa, Mohammad A. Sahraian, Miklós Szólics, Abdulrahman AlTahan, Bassem I. Yamout, Peter Rieckmann, Abdulkader Daif
Publikováno v:
Multiple Sclerosis International, Vol 2013 (2013)
The prevalence of multiple sclerosis (MS) is now considered to be medium-to-high in the Middle East and is rising, particularly among women. While the characteristics of the disease and the response of patients to disease-modifying therapies are gene
Externí odkaz:
https://doaj.org/article/38bf6d1c13aa4f1997811e165175742b
Autor:
Bassem Yamout, S. Koussa, Taoufik Alsaadi, Mona AlKhawajah, Mohammed Aljumah, Maurice Dahdaleh, Magd Zakaria, Jihad Inshasi, Saeed Bohlega, Raed Alroughani, S Daodi, Samia J. Khoury, R. Goueider, I. Alsharoqi, A. Almahdawi, E. Slassi, Mohammed A. Sahraian, J. Al Khaburi, Saher Hashem
Publikováno v:
Multiple sclerosis and related disorders. 37
With evolving diagnostic criteria and the advent of new oral and parenteral therapies for MS, most current diagnostic and treatment algorithms need revision and updating. The diagnosis of MS relies on incorporating clinical and paraclinical findings
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3fa26a8e6e8366c561824eed9e4394e6
https://pubmed.ncbi.nlm.nih.gov/31670208
https://pubmed.ncbi.nlm.nih.gov/31670208
Autor:
Rana Karabudak, Abdulkader Daif, I. Alsharoqi, Karim Taha, Raed Alroughani, Maurice Dahdaleh, Dirk Deleu, Saeed Bohlega, Mohammed A. Sahraian, Magd Zakaria, Mohammed Aljumah, Abdulrahman Al-Tahan, Jihad Inshasi, Bassem I Yammout
Publikováno v:
The International journal of neuroscience. 127(10)
Disease-modifying therapies (DMTs) delay or may prevent the progression of patients with high-risk clinically isolated syndrome (CIS) to clinically definite multiple sclerosis (MS), and from relapsing-remitting MS to secondary progressive MS. Current
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f2fedf1efb467db1b9767b13b178dff4
https://pubmed.ncbi.nlm.nih.gov/28029270
https://pubmed.ncbi.nlm.nih.gov/28029270
Publikováno v:
Journal of the Neurological Sciences. 405:331
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::acf9b93a677740743fed38a34cffc9ce
https://doi.org/10.1016/j.jns.2019.10.1450
https://doi.org/10.1016/j.jns.2019.10.1450
Autor:
Bassem Yamout, Mohammad Ali Sahraian, Jihad Inshasi, Saeed Bohlega, Magd Zakaria, Mohammed Al Jumah, Abdurahman AlTahan, Oscar Fernández, Nikolaos Grigoriadis, Maurice Dahdaleh, Natalia Totolyan, I. Alsharoqi, Abdulkader Daif, Ayse Altintas, Raed Alroughani, Rana Karabudak, Karim Taha, Dirk Deleu
Publikováno v:
Multiple Sclerosis International, Vol 2016 (2016)
Multiple Sclerosis International
Multiple Sclerosis International
The burden of multiple sclerosis (MS) in women of childbearing potential is increasing, with peak incidence around the age of 30 years, increasing incidence and prevalence, and growing female : male ratio. Guidelines recommend early use of disease-mo
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ad1c3604632adb173007f20085e7012a
http://hdl.handle.net/11655/15719
http://hdl.handle.net/11655/15719
Autor:
Jihad Inshasi, Mohammed Al Jumah, Maurice Dahdaleh, Abdel Rahman Al Tahan, Dirk Deleu, Miklos Szolics, I. Alsharoqi, Ahmad Khalifa, Saeed Bohlega, Bassem Yamout
Publikováno v:
International Journal of Neuroscience. 121:171-175
Treatment adherence to disease modifying drugs (DMDs) in multiple sclerosis is sub-optimal. This, in turn, can affect patients' long-term responses to therapy. A key factor that influences treatment adherence is the need for self-injection of DMDs, w
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::53e684ecf393aa31af555fd182e9b902
https://doi.org/10.3109/00207454.2010.541572
https://doi.org/10.3109/00207454.2010.541572
Autor:
Bassem Yamout, J. Al Khaburi, Samia J. Khoury, Maurice Dahdaleh, Mohammed Aljumah, I. Alsharoqi, Mohammad Ali Sahraian, Saeed Bohlega, Jihad Inshasi, S. Hashem, Raed Alroughani, Salam Koussa, Magd Zakaria, Z. Alkawi, R. Goueider, Taoufik Alsaadi
Publikováno v:
Current medical research and opinion. 31(7)
With evolving diagnostic criteria and the advent of new oral and parenteral therapies for MS, most current diagnostic and treatment algorithms need re-evaluation and updating. The diagnosis of MS relies on incorporating clinical and paraclinical find
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a09a7c07efe19bb46d2fa96c755b8e21
https://pubmed.ncbi.nlm.nih.gov/25946578
https://pubmed.ncbi.nlm.nih.gov/25946578
Autor:
Mohammad Ali Sahraian, Saeed Bohlega, Raed Alroughani, Dirk Deleu, Khaled Esmat, Maurice Dahdaleh, Mohammed Aljumah, Miklos Szolics, Abdulrahman Al-Tahan, I. Alsharoqi, Abdulkader Daif, Ahmad Khalifa, Bassem Yamout, Peter Rieckmann
Publikováno v:
Multiple Sclerosis International
Multiple Sclerosis International, Vol 2013 (2013)
Multiple Sclerosis International, Vol 2013 (2013)
The prevalence of multiple sclerosis (MS) is now considered to be medium-to-high in the Middle East and is rising, particularly among women. While the characteristics of the disease and the response of patients to disease-modifying therapies are gene
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ec4fb758c053fb2dddf76bd2a6e21c0d
http://europepmc.org/articles/PMC3877627
http://europepmc.org/articles/PMC3877627
Autor:
S. Hashem, N Abouzeid, Maurice Dahdaleh, Jihad Inshasi, K ElKallab, Raed Alroughani, Saeed Bohlega, Taoufik Alsaadi, T Tawfeek, Samia J. Khoury, Mohammed Aljumah, Magd Zakaria, Bassem Yamout, I. Alsharoqi
Publikováno v:
Current medical research and opinion. 29(6)
The diagnosis of multiple sclerosis (MS) is dependent on the presence of clinical and paraclinical evidence demonstrating dissemination of central nervous system lesions in both space and time, as well as the exclusion of other disorders. Diagnostic
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4d6a2c3090f8cf66d6f518823080d023
https://pubmed.ncbi.nlm.nih.gov/23514115
https://pubmed.ncbi.nlm.nih.gov/23514115